Clinical Trial Update: A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the effect of VI-0521 on cardiac repolarization in healthy male and female volunteers. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Torsades De Pointes

Drugs mentioned

• VI-0521

Snippet

Sponsor: VIVUS LLC | Conditions: Torsades de Pointes | Phase 1 | Status: COMPLETED